Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLT: CMV Vaccine in Liver Transplant Candidates
NCT06075745Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2024
- Primary completion
- Jun 2027
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Triplex in cytomegalovirus infection (CMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2024; status: recruiting.
02
Drugs
Triplex
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT06075745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06075745.